6505--Bulk Order Impavido (miltefosine)

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 (VISN 20) has issued a Special Notice for a sole-source procurement of Impavido (miltefosine), a specialized pharmaceutical product. The notice, identified with the Federal Contract Opportunity ID a67b4d302e874c6885572992645db2e1, was posted on April 22, 2025, with a response deadline of April 23, 2025. The procurement is specifically for the Puget Sound VA Medical Center and focuses on acquiring a unique medication for treating Disseminated Cutaneous Acanthamboeba. The total contract value is $299,700.00, with a performance period from May 1, 2025, to October 30, 2025. The sole-source justification is based on Profounda, Inc. being the exclusive manufacturer and licenseholder of this medication in the United States.

The primary objective of this Special Notice is to procure Impavido through a sole-source procurement method under the "Only One Responsible Source" authority. Contractors should note the response deadline is April 23, 2025, at 1:00 PM Pacific Time, with the solicitation number 36C26025P0684. The procurement is categorized under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing) and Product Service Code 6505 (Drugs and Biologicals). Eligibility is effectively limited to Profounda, Inc., as market research confirmed they are the only vendor capable of providing this specific medication. The point of contact for this opportunity is Jose E. Ronstadt, who can be reached at jose.ronstadt@va.gov or 360-852-9885. Profounda, Inc. has been verified as registered in multiple systems including SAM, SBA, IFCAP, and Pharmacy Sharpoint, and the cost has been deemed fair and reasonable based on previous purchase orders for the same medication.